TY - JOUR
T1 - Novel 3-chloro-6-nitro-1H-indazole derivatives as promising antileishmanial candidates
T2 - synthesis, biological activity, and molecular modelling studies
AU - Mohamed Abdelahi, Mohamed Mokhtar
AU - El Bakri, Youness
AU - Lai, Chin Hung
AU - Subramani, Karthikeyan
AU - Anouar, El Hassane
AU - Ahmad, Sajjad
AU - Benchidmi, Mohammed
AU - Mague, Joel T.
AU - Popović-Djordjević, Jelena
AU - Goumri-Said, Souraya
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - An efficient pathway was disclosed for the synthesis of 3-chloro-6-nitro-1H-indazole derivatives by 1,3-dipolar cycloaddition on dipolarophile compounds 2 and 3. Faced the problem of separation of two regioisomers, a click chemistry method has allowed us to obtain regioisomers of triazole-1,4 with good yields from 82 to 90% were employed. Also, the antileishmanial biological potency of the compounds was achieved using an MTT assay that reported compound 13 as a promising growth inhibitor of Leishmania major. Molecular docking demonstrated highly stable binding with the Leishmania trypanothione reductase enzyme and produced a network of hydrophobic and hydrophilic interactions. Molecular dynamics simulations were performed for TryR-13 complex to understand its structural and intermolecular affinity stability in a biological environment. The studied complex remained in good equilibrium with a structure deviation of ∼1–3 Å. MM/GBSA binding free energies illustrated the high stability of TryR-13 complex. The studied compounds are promising leads for structural optimisation to enhance the antileishmanial activity.
AB - An efficient pathway was disclosed for the synthesis of 3-chloro-6-nitro-1H-indazole derivatives by 1,3-dipolar cycloaddition on dipolarophile compounds 2 and 3. Faced the problem of separation of two regioisomers, a click chemistry method has allowed us to obtain regioisomers of triazole-1,4 with good yields from 82 to 90% were employed. Also, the antileishmanial biological potency of the compounds was achieved using an MTT assay that reported compound 13 as a promising growth inhibitor of Leishmania major. Molecular docking demonstrated highly stable binding with the Leishmania trypanothione reductase enzyme and produced a network of hydrophobic and hydrophilic interactions. Molecular dynamics simulations were performed for TryR-13 complex to understand its structural and intermolecular affinity stability in a biological environment. The studied complex remained in good equilibrium with a structure deviation of ∼1–3 Å. MM/GBSA binding free energies illustrated the high stability of TryR-13 complex. The studied compounds are promising leads for structural optimisation to enhance the antileishmanial activity.
KW - 1,2,3-Triazole
KW - antileishmanial activity
KW - isooxazoline
KW - isoxazole
KW - molecular dynamics
UR - http://www.scopus.com/inward/record.url?scp=85121289833&partnerID=8YFLogxK
U2 - 10.1080/14756366.2021.1995380
DO - 10.1080/14756366.2021.1995380
M3 - Article
C2 - 34894940
AN - SCOPUS:85121289833
SN - 1475-6366
VL - 37
SP - 151
EP - 167
JO - Journal of Enzyme Inhibition and Medicinal Chemistry
JF - Journal of Enzyme Inhibition and Medicinal Chemistry
IS - 1
ER -